Utilizing SDF‐1's ability to recruit MSCs and metformin's effect in reducing ROS levels, the system activates osteogenesis under high‐glucose conditions through the AMPK/β‐catenin pathway, thereby promoting periodontal bone regeneration in a T2DM environment. This evidence concerns the gene CXCL12 and type 2 diabetes mellitus.